Overview
Brian Till is an Oncologist in Seattle, Washington. Dr. Till is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Follicular Lymphoma. Dr. Till is currently accepting new patients.
His clinical research consists of co-authoring 94 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Cutaneous T-Cell Lymphoma (CTCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Franciscan Oncology At St. Joseph
"Joseph Rosales, MD, has been a physician for over 20 years and a hematologist-oncologist in Western Washington since 2011 -- in Seattle, Federal Way and Tacoma. He is experienced in general hematology and oncology, with specialties in breast and thoracic oncology. Dr. Rosales considers himself a guide in his patients’ therapeutic journey. He meets his patients wherever they are - physically and emotionally - and strives to provide them the knowledge and perspective required to navigate difficult decisions in their care. His treatment philosophy has been consistent: to make sure that the patient remains in as much control of their care as possible while getting the best care possible.Dr. Rosales also maintains activity within the community, including involvement in oncologic education and advocacy. He received the2022 Binaytara Foundation for Excellence in Cancer Care ""Rising Star in Health Equity"" awardfor his demonstration of excellent leadership in improving cancer care in underprivileged communities.Multidisciplinary Lung Cancer Treatment during Covid-19 Video". Dr. Rosales is rated as a Distinguished provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and Bone Marrow Aspiration.
Swedish Health Services
Ning Dong is a Hematologist Oncology specialist and a Hematologist in Issaquah, Washington. Dr. Dong is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Dong is currently accepting new patients.
The Association Of University Physicians
Elizabeth Loggers is an Oncologist and a Hematologist in Seattle, Washington. Dr. Loggers is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, Angiosarcoma, and Liver Embolization. Dr. Loggers is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mantle Cell Lymphoma (MCL)
- Non-Hodgkin LymphomaDr. Till isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- B-Cell LymphomaDr. Till isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Till isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Till isDistinguished. Learn about Follicular Lymphoma.
- Multiple MyelomaDr. Till isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Classical Hodgkin LymphomaDr. Till isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Till isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic Lymphoma
- Primary Lymphoma of the BrainDr. Till isAdvanced. Learn about Primary Lymphoma of the Brain.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Till isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Till isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Burkitt LymphomaDr. Till isExperienced. Learn about Burkitt Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Till isExperienced. Learn about Childhood Acute Myeloid Leukemia.